News
A Delaware federal jury said on Friday that Revance Therapeutics owes AbbVie's Allergan Inc $56 million after finding that ...
AbbVie and its subsidiary Allergan have had a long run of unchallenged success in the market with cosmetic and therapeutic ...
A federal jury in Delaware found that Revance's rival product infringed patents for Allergan's market-leading neurotoxin ...
Allergan Aesthetics, an AbbVie company (NYSE: ABBV), today announced the 2025 class of entrepreneurs who will participate in ...
A federal jury July 18 said Revance Therapeutics' skin medication infringed on patents for anti-wrinkle treatment Botox and owes AbbVie-owned Allergan $56 million.
A MUM was terrified her boob job would kill her after it led to a rare disease. Colette Cooper went under the knife in 2014 ...
Pfizer and Allergan said the effective tax rate of the new company would be 17% to 18%, well below Pfizer’s effective tax rate last year of 25.5%.
Lab workers examine samples at an Allergan research site in France. A U.S. judge has cast doubt on the company’s scheme to protect its drug patents by trading them to a New York Indian tribe.
U.S. pharmaceutical giant Pfizer (PFE) and Irish rival Allergan (AGN) Monday announced a record-breaking $160-billion merger, the largest in health-care industry history and the biggest yet ...
Actavis is nearing a deal to acquire Allergan in a tie-up that would likely be the year’s largest and could help shield the Botox maker from hostile suitor Valeant.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results